Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers

A molecular mimicry between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human proteins supports the possibility that autoimmunity takes place during coronavirus disease 2019 (COVID-19) contributing to tissue damage. For example, anti-phospholipid antibodies (aPL) have been repor...

Full description

Bibliographic Details
Main Authors: Maria Orietta Borghi, Mauro Bombaci, Caterina Bodio, Paola Adele Lonati, Andrea Gobbini, Mariangela Lorenzo, Erminio Torresani, Antonella Dubini, Ilaria Bulgarelli, Francesca Solari, Francesca Pregnolato, Alessandra Bandera, Andrea Gori, Gianfranco Parati, Sergio Abrignani, Renata Grifantini, Pier Luigi Meroni
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.930074/full
_version_ 1828462211805216768
author Maria Orietta Borghi
Maria Orietta Borghi
Mauro Bombaci
Caterina Bodio
Paola Adele Lonati
Andrea Gobbini
Mariangela Lorenzo
Erminio Torresani
Antonella Dubini
Ilaria Bulgarelli
Francesca Solari
Francesca Pregnolato
Alessandra Bandera
Alessandra Bandera
Alessandra Bandera
Andrea Gori
Andrea Gori
Andrea Gori
Gianfranco Parati
Gianfranco Parati
Sergio Abrignani
Sergio Abrignani
Renata Grifantini
Pier Luigi Meroni
author_facet Maria Orietta Borghi
Maria Orietta Borghi
Mauro Bombaci
Caterina Bodio
Paola Adele Lonati
Andrea Gobbini
Mariangela Lorenzo
Erminio Torresani
Antonella Dubini
Ilaria Bulgarelli
Francesca Solari
Francesca Pregnolato
Alessandra Bandera
Alessandra Bandera
Alessandra Bandera
Andrea Gori
Andrea Gori
Andrea Gori
Gianfranco Parati
Gianfranco Parati
Sergio Abrignani
Sergio Abrignani
Renata Grifantini
Pier Luigi Meroni
author_sort Maria Orietta Borghi
collection DOAJ
description A molecular mimicry between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human proteins supports the possibility that autoimmunity takes place during coronavirus disease 2019 (COVID-19) contributing to tissue damage. For example, anti-phospholipid antibodies (aPL) have been reported in COVID-19 as a result of such mimicry and thought to contribute to the immunothrombosis characteristic of the disease. Consistently, active immunization with the virus spike protein may elicit the production of cross-reactive autoantibodies, including aPL. We prospectively looked at the aPL production in healthcare workers vaccinated with RNA- (BNT162b2, n. 100) or adenovirus-based vaccines (ChAdOx1, n. 50). Anti-cardiolipin, anti-beta2 glycoprotein I, anti-phosphatidylserine/prothrombin immunoglobulin G (IgG), IgA, and IgM before and after vaccination were investigated. Anti-platelet factor 4 immunoglobulins were also investigated as autoantibodies associated with COVID-19 vaccination. Additional organ (anti-thyroid) and non-organ (anti-nuclear) autoantibodies and IgG against human proteome were tested as further post-vaccination autoimmunity markers. The antibodies were tested one or three months after the first injection of ChAdOx1 and BNT162b2, respectively; a 12-month clinical follow-up was also performed. Vaccination occasionally induced low titers of aPL and other autoantibodies but did not affect the titer of pre-existing autoantibodies. No significant reactivities against a microarray of approximately 20,000 human proteins were found in a subgroup of ChAdOx1-vaccinees. Consistently, we did not record any clinical manifestation theoretically associated with an underlying autoimmune disorder. The data obtained after the vaccination (two doses for the RNA-based and one dose for the adenovirus-based vaccines), and the clinical follow-up are not supporting the occurrence of an early autoimmune response in this cohort of healthcare workers.
first_indexed 2024-12-11T02:32:08Z
format Article
id doaj.art-5fb6aabe8703441cb969853cdbfd7ca0
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T02:32:08Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-5fb6aabe8703441cb969853cdbfd7ca02022-12-22T01:23:49ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-07-011310.3389/fimmu.2022.930074930074Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare WorkersMaria Orietta Borghi0Maria Orietta Borghi1Mauro Bombaci2Caterina Bodio3Paola Adele Lonati4Andrea Gobbini5Mariangela Lorenzo6Erminio Torresani7Antonella Dubini8Ilaria Bulgarelli9Francesca Solari10Francesca Pregnolato11Alessandra Bandera12Alessandra Bandera13Alessandra Bandera14Andrea Gori15Andrea Gori16Andrea Gori17Gianfranco Parati18Gianfranco Parati19Sergio Abrignani20Sergio Abrignani21Renata Grifantini22Pier Luigi Meroni23IRCCS Istituto Auxologico Italiano, Immunorheumatology Research Laboratory, Milan, ItalyDepartment of Clinical Sciences and Community Health, University of Milan, Milan, ItalyIstituto Nazionale Genetica Molecolare, Padiglione Romeo ed Enrica Invernizzi, Milan, ItalyIRCCS Istituto Auxologico Italiano, Immunorheumatology Research Laboratory, Milan, ItalyIRCCS Istituto Auxologico Italiano, Immunorheumatology Research Laboratory, Milan, ItalyIstituto Nazionale Genetica Molecolare, Padiglione Romeo ed Enrica Invernizzi, Milan, ItalyIstituto Nazionale Genetica Molecolare, Padiglione Romeo ed Enrica Invernizzi, Milan, ItalyIRCCS Istituto Auxologico Italiano, Immunorheumatology Research Laboratory, Milan, ItalyIRCCS Istituto Auxologico Italiano, Immunorheumatology Research Laboratory, Milan, ItalyIRCCS Istituto Auxologico Italiano, Immunorheumatology Research Laboratory, Milan, ItalyIRCCS Istituto Auxologico Italiano, Immunorheumatology Research Laboratory, Milan, ItalyIRCCS Istituto Auxologico Italiano, Immunorheumatology Research Laboratory, Milan, ItalyDepartment of Clinical Sciences and Community Health, University of Milan, Milan, ItalyInfectious Diseases Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, ItalyCentre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, ItalyDepartment of Clinical Sciences and Community Health, University of Milan, Milan, ItalyInfectious Diseases Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, ItalyCentre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, ItalyIRCCS Istituto Auxologico Italiano, Immunorheumatology Research Laboratory, Milan, ItalyDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan, ItalyDepartment of Clinical Sciences and Community Health, University of Milan, Milan, ItalyIstituto Nazionale Genetica Molecolare, Padiglione Romeo ed Enrica Invernizzi, Milan, ItalyIstituto Nazionale Genetica Molecolare, Padiglione Romeo ed Enrica Invernizzi, Milan, ItalyIRCCS Istituto Auxologico Italiano, Immunorheumatology Research Laboratory, Milan, ItalyA molecular mimicry between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human proteins supports the possibility that autoimmunity takes place during coronavirus disease 2019 (COVID-19) contributing to tissue damage. For example, anti-phospholipid antibodies (aPL) have been reported in COVID-19 as a result of such mimicry and thought to contribute to the immunothrombosis characteristic of the disease. Consistently, active immunization with the virus spike protein may elicit the production of cross-reactive autoantibodies, including aPL. We prospectively looked at the aPL production in healthcare workers vaccinated with RNA- (BNT162b2, n. 100) or adenovirus-based vaccines (ChAdOx1, n. 50). Anti-cardiolipin, anti-beta2 glycoprotein I, anti-phosphatidylserine/prothrombin immunoglobulin G (IgG), IgA, and IgM before and after vaccination were investigated. Anti-platelet factor 4 immunoglobulins were also investigated as autoantibodies associated with COVID-19 vaccination. Additional organ (anti-thyroid) and non-organ (anti-nuclear) autoantibodies and IgG against human proteome were tested as further post-vaccination autoimmunity markers. The antibodies were tested one or three months after the first injection of ChAdOx1 and BNT162b2, respectively; a 12-month clinical follow-up was also performed. Vaccination occasionally induced low titers of aPL and other autoantibodies but did not affect the titer of pre-existing autoantibodies. No significant reactivities against a microarray of approximately 20,000 human proteins were found in a subgroup of ChAdOx1-vaccinees. Consistently, we did not record any clinical manifestation theoretically associated with an underlying autoimmune disorder. The data obtained after the vaccination (two doses for the RNA-based and one dose for the adenovirus-based vaccines), and the clinical follow-up are not supporting the occurrence of an early autoimmune response in this cohort of healthcare workers.https://www.frontiersin.org/articles/10.3389/fimmu.2022.930074/fullanti-phospholipid antibodiesSARS-CoV-2 vaccinationautoimmunityautoantibodiesCOVID-19
spellingShingle Maria Orietta Borghi
Maria Orietta Borghi
Mauro Bombaci
Caterina Bodio
Paola Adele Lonati
Andrea Gobbini
Mariangela Lorenzo
Erminio Torresani
Antonella Dubini
Ilaria Bulgarelli
Francesca Solari
Francesca Pregnolato
Alessandra Bandera
Alessandra Bandera
Alessandra Bandera
Andrea Gori
Andrea Gori
Andrea Gori
Gianfranco Parati
Gianfranco Parati
Sergio Abrignani
Sergio Abrignani
Renata Grifantini
Pier Luigi Meroni
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
Frontiers in Immunology
anti-phospholipid antibodies
SARS-CoV-2 vaccination
autoimmunity
autoantibodies
COVID-19
title Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
title_full Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
title_fullStr Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
title_full_unstemmed Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
title_short Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
title_sort anti phospholipid antibodies and coronavirus disease 2019 vaccination does not trigger early autoantibody production in healthcare workers
topic anti-phospholipid antibodies
SARS-CoV-2 vaccination
autoimmunity
autoantibodies
COVID-19
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.930074/full
work_keys_str_mv AT mariaoriettaborghi antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT mariaoriettaborghi antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT maurobombaci antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT caterinabodio antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT paolaadelelonati antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT andreagobbini antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT mariangelalorenzo antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT erminiotorresani antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT antonelladubini antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT ilariabulgarelli antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT francescasolari antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT francescapregnolato antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT alessandrabandera antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT alessandrabandera antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT alessandrabandera antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT andreagori antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT andreagori antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT andreagori antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT gianfrancoparati antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT gianfrancoparati antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT sergioabrignani antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT sergioabrignani antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT renatagrifantini antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers
AT pierluigimeroni antiphospholipidantibodiesandcoronavirusdisease2019vaccinationdoesnottriggerearlyautoantibodyproductioninhealthcareworkers